XML 54 R34.htm IDEA: XBRL DOCUMENT v3.25.4
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
For the years ended December 31, 2025 and 2024, the following table presents total share-based compensation expense in each functional line item on the consolidated statements of operations (in thousands):
 Year Ended December 31,
 20252024
Cost of revenues$375 $126 
Research and development1,023 691 
Sales and marketing824 430 
General and administrative5,219 2,577 
Income from discontinued operations, net of tax— 115 
Total$7,441 $3,939 
Schedule of Share-based Compensation Stock Option Fair Value Assumptions
The following table presents the weighted-average assumptions used in the Black-Scholes valuation model by the Company in calculating the fair value of each stock option granted:
 Year Ended December 31,
 20252024
Expected dividend yield— %— %
Risk-free interest rate3.9 %4.2 %
Volatility94.8 %95.1 %
Expected term (in years)4.84.0
The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)10
Risk-free interest rate4.57 %
Volatility84.00 %
Expected dividend yield— %
The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the Market-based CEO RSUs:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)3
Risk-free interest rate4.25 %
Volatility105.63 %
Expected dividend yield— %
Correlation coefficient0.3741
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity for the years ended December 31, 2025 and 2024 (dollars in thousands, except per share data):
Stock
Options
Outstanding
Weighted-Average
Exercise
Price Per
Option
Weighted-Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
Outstanding — December 31, 2023545,872 $44.16 
Granted44,250 8.40 
Exercised(1,475)15.53 
Canceled(318,796)54.28 
Outstanding — December 31, 2024269,851 $26.49 
Granted1,350,300 15.19 
Exercised(10,440)6.48 
Canceled(92,672)24.32 
Outstanding — December 31, 20251,517,039 $16.70 8.70$1,420 
Vested and Expected to Vest — December 31, 20251,303,162 $17.07 8.61$1,220 
Exercisable — December 31, 2025147,729 $32.81 4.46$273 
Schedule of Restricted Stock Unit Activity
A summary of restricted stock unit activity under all plans for the years ended December 31, 2025 and 2024 is presented below:
Number of SharesWeighted-Average Grant-Date Fair Value
Non-vested — December 31, 2023203,008 19.84 
Granted1,106,862 9.34 
Vested(164,288)13.42 
Forfeited(33,741)31.68 
Non-vested — December 31, 20241,111,841 10.00 
Granted1,251,978 12.69 
Vested(390,926)10.90 
Forfeited(126,737)8.50 
Non-vested — December 31, 20251,846,156 11.65